Anna Kathy Aman

Array ( [id] => 7468311 [patent_doc_number] => 20040167108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/753610 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11555 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167108.pdf [firstpage_image] =>[orig_patent_app_number] => 10753610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181388 [patent_doc_number] => 20040202682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Liquid-liquid interfacial nanoparticle assemblies' [patent_app_type] => new [patent_app_number] => 10/753868 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11617 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202682.pdf [firstpage_image] =>[orig_patent_app_number] => 10753868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672884 [patent_doc_number] => 20040180895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Use of a pyridazinone derivative' [patent_app_type] => new [patent_app_number] => 10/750846 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1759 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180895.pdf [firstpage_image] =>[orig_patent_app_number] => 10750846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163693 [patent_doc_number] => 20050085537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Method and composition for treating osteoporosis' [patent_app_type] => utility [patent_app_number] => 10/747671 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21953 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085537.pdf [firstpage_image] =>[orig_patent_app_number] => 10747671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7239215 [patent_doc_number] => 20040157861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Compositions and methods for inhibiting TGF-beta' [patent_app_type] => new [patent_app_number] => 10/747531 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13164 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157861.pdf [firstpage_image] =>[orig_patent_app_number] => 10747531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963742 [patent_doc_number] => 06949554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-27 [patent_title] => 'Calcium channel blockers comprising two benzhydril moieties' [patent_app_type] => utility [patent_app_number] => 10/746932 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 7 [patent_no_of_words] => 8825 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949554.pdf [firstpage_image] =>[orig_patent_app_number] => 10746932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347201 [patent_doc_number] => 20040192703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Preferentially substituted calcium channel blockers' [patent_app_type] => new [patent_app_number] => 10/746933 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6850 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192703.pdf [firstpage_image] =>[orig_patent_app_number] => 10746933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330206 [patent_doc_number] => 20040254228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Treatment of chronic heart failure' [patent_app_type] => new [patent_app_number] => 10/741709 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4646 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254228.pdf [firstpage_image] =>[orig_patent_app_number] => 10741709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677091 [patent_doc_number] => 20040152735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'NO-synthase inhibitors comprising N,N\'-bis(2-pyridyl)methyl-N,N\'-bis(3,4,5-trimethoxybenzyl) ethylenediamine' [patent_app_type] => new [patent_app_number] => 10/733387 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4933 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152735.pdf [firstpage_image] =>[orig_patent_app_number] => 10733387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677058 [patent_doc_number] => 20040152768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'NO-synthase inhibitors comprising ascorbyl 2-hexadecanoate' [patent_app_type] => new [patent_app_number] => 10/733468 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4467 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152768.pdf [firstpage_image] =>[orig_patent_app_number] => 10733468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675685 [patent_doc_number] => 20040126433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Light stabilized antimicrobial materials' [patent_app_type] => new [patent_app_number] => 10/734784 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2949 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126433.pdf [firstpage_image] =>[orig_patent_app_number] => 10734784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674644 [patent_doc_number] => 20040127474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Regulators of the hedgehog pathway, compositions and uses related thereto' [patent_app_type] => new [patent_app_number] => 10/735116 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 32328 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127474.pdf [firstpage_image] =>[orig_patent_app_number] => 10735116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 996333 [patent_doc_number] => 06913772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-05 [patent_title] => 'Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof' [patent_app_type] => utility [patent_app_number] => 10/735437 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4479 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/913/06913772.pdf [firstpage_image] =>[orig_patent_app_number] => 10735437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270572 [patent_doc_number] => 07563808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Methods for treating cognitive impairments or dementia' [patent_app_type] => utility [patent_app_number] => 10/732349 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8959 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563808.pdf [firstpage_image] =>[orig_patent_app_number] => 10732349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468195 [patent_doc_number] => 20040120986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Liquid oral compositions comprising a calcium compound and an acidulant' [patent_app_type] => new [patent_app_number] => 10/733992 [patent_app_country] => US [patent_app_date] => 2003-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3961 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120986.pdf [firstpage_image] =>[orig_patent_app_number] => 10733992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474111 [patent_doc_number] => 20040122010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Treatment of neuropathy' [patent_app_type] => new [patent_app_number] => 10/731905 [patent_app_country] => US [patent_app_date] => 2003-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9631 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122010.pdf [firstpage_image] =>[orig_patent_app_number] => 10731905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672917 [patent_doc_number] => 20040180862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Compositions and methods for inhibiting bone resorption' [patent_app_type] => new [patent_app_number] => 10/479922 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6117 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180862.pdf [firstpage_image] =>[orig_patent_app_number] => 10479922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1018047 [patent_doc_number] => 06890941 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Compositions containing HMG Co-A reductase inhibitors and policosanol' [patent_app_type] => utility [patent_app_number] => 10/725405 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7155 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890941.pdf [firstpage_image] =>[orig_patent_app_number] => 10725405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411432 [patent_doc_number] => 20040176456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Method of treatment for sexual dysfunction' [patent_app_type] => new [patent_app_number] => 10/726878 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6864 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176456.pdf [firstpage_image] =>[orig_patent_app_number] => 10726878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291408 [patent_doc_number] => 20040110800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Use of glucose uptake enhancer for reducing post-ischemic injury of the heart' [patent_app_type] => new [patent_app_number] => 10/725667 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4817 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110800.pdf [firstpage_image] =>[orig_patent_app_number] => 10725667 [rel_patent_id] =>[rel_patent_doc_number] =>)